Visa Launches Commercial Integrated Partners to Turbo-Charge the Fintech Ecosystem
21.5.2025 13:00:00 CEST | Business Wire | Press Release
Visa (NYSE:V), a global leader in digital payments, announced Visa Commercial Integrated Partners, a new program designed to improve connectivity between fintechs and Visa Commercial products through its commercial platform. Visa will make available advanced APIs to embed Visa products in a business partners’ applications and make these integrations available to its financial institution clients, allowing them to offer new, seamless payment experiences to their business customers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250521378181/en/
Empowering Fintechs and Financial Institutions
Visa Commercial Integrated Partners is providing the ecosystem, technology and framework for innovative fintechs and other business application providers to integrate payment functionalities into their platforms with ease and enable Visa credentials offered by Visa Commercial issuers.
For example, the Visa Commercial Integrated Partners program allows financial institutions that use Visa’s commercial platform to offer their customers virtual payments and data solutions, instead of having to complete direct technical integrations with these applications such as ERP or Fleet Management platforms. This helps financial institutions avoid long or costly technical development and investments in resources.
One of Visa’s first partners in the program, Car IQ, is a leader in fleet and vehicle technology, and is enabling integration with the commercial platform. Clients will soon be able to access Car IQ software for their business customers and enable in-app payments with virtual cards at fuel providers, without extensive supplier onboarding or development, potentially saving 18-24 months of due diligence, integration work and project management.
This also benefits Visa business partners in the program by reducing their development time and costs, enabling fintechs to focus on innovation and enhancing customer experiences, while providing their customers with the ability to make payments with existing Commercial Card credentials.
Financial institutions can leverage Visa Commercial Integrated Partners to offer customers enhanced payment solutions, such as payments in ERPs, expense management, mobile and vehicle apps, offer tokenization through virtual cards, more elaborate transaction controls and enhanced data on settlements. This not only improves the customer experience but also strengthens the institution’s commercial card product offerings and competitive position in the market.
Through Visa Commercial Integrated Partners, financial institutions can access pre-evaluated fintech partners already integrated with Visa, driving faster adoption and implementation.
"Visa Commercial Integrated Partners represents a significant step forward in our mission to empower financial technology providers and financial institutions with innovative digital payment solutions," said Darren Parslow, Global Head of Visa Commercial Solutions. "By leveraging our network and Commercial APIs, we are enabling our partners to innovate faster, reduce development and distribution costs and deliver superior payment experiences to their clients – it underscores Visa's commitment to driving the future of digital payments and supporting the growth of the fintech ecosystem globally."
"Our digital payment infrastructure enables issuing banks to offer commercial customers a fleet solution that will enable them to connect their fleet vehicles directly to their existing Visa line of credit," said Sterling Pratz, Founder and CEO of Car IQ. "We believe transforming the vehicle into a Visa payment credential for fuel, tolls, and services will help banks recapture fleet spend that is currently lost to legacy card programs and private networks."
Global Reach with Local Implementation
Visa Commercial Integrated Partners is designed to support a global network of business partners while addressing local market needs. Collaborating with regional fintechs and financial institutions helps ensure that Visa solutions are relevant and effective across different markets.
The program is built on a global framework, allowing for consistent contracting models, data privacy, technology integrations, risks and security standards worldwide. Visa also works closely with regional partners to tailor solutions to specific market requirements, supporting a diverse range of partners from global enterprises to local startups.
Continuous Innovation
Visa is dedicated to driving innovation in the payments industry, and Visa Commercial Integrated Partners provides business partners with access to the latest payment technologies, enabling continuous improvement and adaptation to emerging trends and needs.
Visa invites fintechs to join the Visa Commercial Integrated Partners program and financial institutions to enable business partners and their portfolios to be part of the future of payments.
For more information about the Visa Commercial Integrated Partners Program and how to join, visit Visa Commercial Integrated Partners | Visa.
About Visa Inc.
Visa (NYSE: V) is a world leader in digital payments, facilitating transactions between consumers, merchants, financial institutions and government entities across more than 200 countries and territories. Our mission is to connect the world through the most innovative, convenient, reliable and secure payments network, enabling individuals, businesses and economies to thrive. We believe that economies that include everyone everywhere, uplift everyone everywhere and see access as foundational to the future of money movement. Learn more at Visa.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250521378181/en/
Contacts
David Thum
dthum@visa.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom